Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Go back to Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
(NASDAQ: VRDN) Delayed: 16.15 +0.38 (2.41%)
Previous Close $15.77    52 Week High
Open $15.75    52 Week Low
Day High $16.22    P/E N/A 
Day Low $15.62    EPS
Volume 971,945